Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Leonardo Biosystems
AddedFeb 17, 2024
UpdatedJun 18, 2026
Leonardo Biosystems

Leonardo Biosystems

Pre-Seed

Leonardo Biosystems: Pioneering nanotech-based, multi-stage drug delivery solutions for targeted cancer treatment.

HQ
Houston, TX, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Leonardo Biosystems specializes in advanced drug delivery solutions, focusing on nanotechnology-based platforms for targeted cancer treatment. The company's core mission is to overcome biological barriers that hinder the development and commercialization of injectable drug therapies. Their innovative multi-stage drug delivery system aims to revolutionize cancer treatment by enhancing the precision and efficacy of drug administration.

The company's pioneering approach has positioned it as a significant player in the field of nanomedicine and oncology. Leonardo Biosystems offers custom drug delivery solutions, leveraging its proprietary technology to address specific challenges in cancer treatment. Their work represents a crucial step forward in the ongoing effort to improve patient outcomes and reduce side effects associated with traditional cancer therapies.

Leonardo Biosystems - Similar Companies

NanoMedical Systems logo

NanoMedical Systems

nanomedsys.com

Advanced NanoTherapies logo

Advanced NanoTherapies

Lypro Biosciences logo

Lypro Biosciences

lyprobio.com

Zenomics logo

Zenomics

Nanotransfer logo

Nanotransfer

nanotransfer.bio

Control Delivery Systems logo

Control Delivery Systems

Souvie Biodelivery logo

Souvie Biodelivery

Nano RED logo

Nano RED

Vali Nanomedical logo

Vali Nanomedical

Optimeos Life Sciences logo

Optimeos Life Sciences

optimeos.com

NanoPharmaceuticals logo

NanoPharmaceuticals

Cello Therapeutics logo

Cello Therapeutics

cellothera.com

ZY Therapeutics logo

ZY Therapeutics

zytinc.com

Credence MedSystems logo

Credence MedSystems

Atom Bioworks logo

Atom Bioworks

atombioworks.com

Leonardo Biosystems - Quick Facts

Who are Leonardo Biosystems' competitors?

Companies similar to Leonardo Biosystems include NanoMedical Systems, Advanced NanoTherapies, Lypro Biosciences and Zenomics.

When was Leonardo Biosystems founded?

Leonardo Biosystems was founded in 2005.

Where is Leonardo Biosystems' headquarters located?

Leonardo Biosystems' headquarters is located in Houston, TX, US.

When was Leonardo Biosystems' last funding round?

Leonardo Biosystems' most recent funding round was for $1.3M (USD) in November 2011.

How much has Leonardo Biosystems raised to-date?

As of Nov 14, 2011, Leonardo Biosystems has raised a total of $2.5M (USD).

How many employees does Leonardo Biosystems have?

Leonardo Biosystems has 6 employees as of Feb 5, 2024.

Leonardo Biosystems - Classification

Ownership
  • Private
Technology
  • Nanotechnology
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified